Tag Archives: Non-Disclosure

Process For Review of Confidentiality/ Non-Disclosure Agreements

In an effort to improve efficiency and the handling of confidential/non-disclosure agreements (CDAs/NDAs), the OSP Contracts Unit has established a listserv e-mail address to send CDAs requiring review and institutional signature. Effective February 1, 2012, all clinical trial related CDAs/NDAs requiring review and institutional signature should be sent to the listserv e-mail. The listserv e-mail […]

Posted in Compliance, OSP | Also tagged , | Comments closed